Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Health Psychol ; 2022 Oct 10.
Article in English | MEDLINE | ID: covidwho-2062165

ABSTRACT

OBJECTIVES: Previous research on COVID-19 vaccination hesitancy has found that sociodemographic factors including sex, age, education, and occupation were associated with vaccination acceptance, along with other variables like trust in authorities, risk perception of COVID-19 and perception of vaccine efficacy and safety. However, this research has been limited by the use of nonvalidated measures for vaccination hesitancy and utilizing general samples that did not focus on minoritized groups. The purpose of the current study was to use validated methodology to determine factors associated with vaccination uptake in a community sample of predominantly Black and Latinx adults. METHOD: One-hundred and 9 participants (70% female, 40% Black, 40% Latinx) completed a survey assessing sociodemographic variables, vaccination uptake, medical mistrust, and vaccination attitudes. RESULTS: Multivariate logistic regression revealed that higher scores on the mistrust of the vaccine benefit subscale were associated with lower vaccination uptake (OR = .45, p < .001) and higher levels of education were associated with higher levels of vaccination uptake (OR = 1.56; p = .048). No other demographic variables, nor other aspects of vaccination hesitancy, were associated with vaccination uptake. CONCLUSIONS: Taken together, our findings speak to the importance of dispelling misinformation and building community trust in public health efforts. Specifically, vaccine mistrust may be an especially important focus of community-based education efforts. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

2.
Transl Behav Med ; 11(12): 2123-2126, 2021 12 14.
Article in English | MEDLINE | ID: covidwho-1294783

ABSTRACT

The COVID-19 pandemic has highlighted the inequitable access to resources, leading to a disproportionate burden of disease in vulnerable communities in the USA. However, these inequities in health outcomes are not limited to COVID-19. Approximately 18% of cancers are related to dietary behaviors and excess body weight. Underserved communities, such as minority racial/ethnic groups living in neighborhoods of low socioeconomic status, experience barriers to healthy eating including lack of access to high-quality healthy foods and higher availability of unhealthy foods and beverages in local retail food outlets. Strikingly, these same populations are more likely to die from cancers related to dietary intake and obesity like colorectal, liver, and pancreatic cancers. To reduce cancer inequities, policy makers can act by supporting programs that incentivize healthy food purchases and improve the local food environment in underserved communities.


Subject(s)
COVID-19 , Neoplasms , Humans , Neoplasms/epidemiology , Neoplasms/prevention & control , Pandemics , Policy , SARS-CoV-2
3.
Transl Behav Med ; 11(8): 1635-1637, 2021 08 13.
Article in English | MEDLINE | ID: covidwho-1246756

ABSTRACT

COVID-19 has caused drastic increases in family stress contributing to deleterious social and emotional ramifications. Before COVID-19, millions of Americans lacked access to mental health resources, and now in the midst of a global pandemic, resources are more limited in times of greater need. In March 2020, the Coronavirus Aid, Relief, and Economic Security (CARES) Act provided funding for mental health reforms; yet many barriers remained to receiving sufficient care. In February 2021, the Society of Behavioral Medicine recommended federal legislators expand Community Behavioral Healthcare Centers, increase funding for Federally Qualified Healthcare Centers and School Based Health Centers, incentivize providers to accept Medicaid, and institute more statewide licensing flexibilities to expand the reach of mental health care. In March 2021, the American Rescue Plan was signed into law and provided an additional ~$4 billion in funding for community mental health services, implementing substance abuse prevention and treatment programs, increasing the behavioral health workforce, promoting behavioral telehealth within primary care, increasing school-based mental health services, implementing suicide prevention programs, and improving services for traumatized families. This significant investment in parents and children's mental health is a tremendous step in the right direction and provides reassurance that relief is underway. Ongoing surveillance of the programmatic and clinical outcomes that result from these new policy reforms will be important for identifying areas that may need continual support as our nation recovers from COVID-19.


Subject(s)
Behavioral Medicine , COVID-19 , Mental Health Services , Child , Humans , Parents , SARS-CoV-2 , United States/epidemiology
4.
Transl Behav Med ; 10(3): 516-519, 2020 08 07.
Article in English | MEDLINE | ID: covidwho-1010650

ABSTRACT

The COVID-19 pandemic is the greatest global public health crisis since the 1918 influenza outbreak. As of early June, the novel coronavirus has infected more than 6.3 million people worldwide and more than 1.9 million in the United States (US). The total number of recorded deaths due to COVID-19 are growing at an alarming rate globally (³383,000) and nationally (³109,000) Evidence is mounting regarding the heavier burden of COVID-19 infection, morbidity, and mortality on the underserved populations in the US. This commentary focuses on this global health pandemic and how mitigation of the virus relies heavily on health behavior change to slow its spread, highlighting how the pandemic specifically affects the most socially and economically disadvantaged populations in the US. The commentary also offers short, intermediate and long-term research and policy focused recommendations. Both the research and policy recommendations included in this commentary emphasize equity-driven: (1) research practices, including applying a social determinants and health equity lens on monitoring, evaluation, and clinical trials activities on COVID-19; and (2) policy actions, such as dedicating resources to prioritize high-risk communities for testing, treatment, and prevention approaches and implementing organizational, institutional, and legislative policies that address the social and economic barriers to overall well-being that these populations face during a pandemic. It is our hope that these recommendations will generate momentum in delivering timely, effective, and lifesaving changes.


Subject(s)
Betacoronavirus , Biomedical Research/methods , Coronavirus Infections/epidemiology , Health Policy/legislation & jurisprudence , Health Status Disparities , Pandemics/legislation & jurisprudence , Pneumonia, Viral/epidemiology , COVID-19 , Humans , SARS-CoV-2 , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL